Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer's disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22407491.
- Also identified by DOI 10.1002/adma.201104864.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A novel strategy to dissociate amyloid aggregation is presented, using localised heat generation from a clinically used amyloid staining dye, thioflavin-S (ThS)-modified graphene oxide (GO) under NIR laser irradiation. Compared to traditional chemotherapies, photothermal therapy shows reduced side effects and improved selectivity and safety.
Medical subject headings
- Alzheimer Disease
- Amyloid
- Graphite
- Hyperthermia, Induced
- Oxides
- Phototherapy
- Thiazoles